Briagen Observational Study (BOS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04090970|
Recruitment Status : Recruiting
First Posted : September 16, 2019
Last Update Posted : September 17, 2019
|Condition or disease||Intervention/treatment|
|Mohs Surgery||Device: Briagen|
Briagen, the study product being used in this study, is a natural complex carbohydrate wound dressing for skin wounds created by Mohs surgery.
Briagen was developed with the intent to improve healing time and reduce scarring of skin wounds. Briagen seeks to match the mechanical aspects of your skin (thickness, stiffness, hydration, pore size) to assist in the healing process.
The purpose of this research study is to observe healing time of Briagen applied to wounds created as a result of Mohs surgery.
|Study Type :||Observational|
|Estimated Enrollment :||12 participants|
|Official Title:||Gemstone Biotherapeutics Briagen™ Case Study and Observation of Mohs Excision Healing|
|Actual Study Start Date :||August 26, 2019|
|Estimated Primary Completion Date :||March 2020|
|Estimated Study Completion Date :||May 2020|
- Device: Briagen
Natural complex carbohydrate wound dressing for skin wounds
- Healing Time [ Time Frame: 28 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04090970
|Contact: Emily English, PhDfirstname.lastname@example.org|
|United States, New Jersey|
|Dr. David Abramson||Recruiting|
|Englewood, New Jersey, United States, 07631|
|Contact: David Abramson, MD 201-568-2977|